Dr Gavin Meehan is an Associate Scientific Director at RoukenBio, where he leads the company’s Autoimmunity Service - driving the development of advanced human primary cell in vitro models to support therapeutic innovation across autoimmune disease research. With a scientific career spanning pharmacology, virology, translational immunology and diagnostics Dr Meehan brings a uniquely broad perspective to immune‑targeted drug discovery.
With a PhD in Neuroimmunology from the University of Glasgow, Dr Meehan has built extensive experience across both academia and industry since 2015. His work has spanned a range of autoimmune diseases, including Guillain-Barré syndrome, multifocal motor neuropathy, scleroderma, and rheumatoid arthritis. He has developed a particular interest in antibody characterisation, T cell biology and dendritic cell immunology.
As the leader of the Autoimmunity Team, he oversees the design and execution of cutting‑edge immune assays that support partners throughout the drug development pipeline. His team focuses on mechanistic immunology, functional T‑ and B‑cell responses, and bespoke model development tailored to autoimmune biology.
Resources
Insights
18 February 2026
|9 min read
Dr Gavin R Meehan, Associate Scientific Director of Immunology, previously discussed the rapid pivot from immuno oncology into autoimmunity and the ripple effects it is having across drug discovery and the wider therapeutic market. In this new article, he builds upon those earlier observations and explores the type of autoimmune focused modalities that are gaining traction in today’s immunotherapy pipelines and how RoukenBio is evolving its capabilities in response.
Insights
13 October 2025
|6 min read
Recent advances in immuno-oncology, especially CAR-T cell therapies, have inspired a shift in drug development towards treating autoimmune diseases, as demonstrated by successful trials in conditions like systemic lupus erythematosus. We are now seeing a significant increase in autoimmunity projects, leveraging shared immune pathways and repurposing existing cancer therapies to accelerate discovery and reduce development time.
Insights
21 April 2025
|6 min read
On World Immunology Day, we celebrate the passion and purpose that drive our team at the Rouken Discovery Centre, honouring the science behind every assay, breakthrough, and the immune system’s incredible potential to change lives.
